KDDI, a major Japan-based telecommunications provider has validated IP Infusion’s Disaggregated Cell Site Gateway Solution (DCSG), announced IP Infusion on Tuesday.
In a lab trial conducted by KDDI, the DCSG solution successfully completed rigorous Telecom Infra Project (TIP) compliance and KDDI’s requirements in telco network environments. The testing covered a variety of use cases, including performance and functional/feature testing.
